This script search US Code. View Rule
Skip past Nav Bar
GSA - U.S. General Services Administration Office of Management and Budget
RegInfo.gov Where to find Federal Regulation Information US Flag
Home
Background Image Spacer Unified Agenda and Regulatory Plan Spacer EO 12866 Regulatory Review Spacer Information Collection Review
Current Unified Agenda and Regulatory Plan Historical Unified Agenda and Regulatory Plan Search

View Rule


HHS/FDA RIN: 0910-AF67 Publication ID: Fall 2007 
Title: Index of Legally Marketed Unapproved New Animal Drugs for Minor Species 
Abstract: This rule is being issued in response to the Minor Use and Minor Species (MUMS) Animal Health Act of 2004. The rule implements section 572 of the MUMS Act, which provides for a public index listing of legally marketed unapproved new animal drugs for minor species of animals (species other than cattle, horses, swine, chickens, turkeys, dogs, and cats). The drugs in this index will only be indicated for use in non-food minor species or for use in early non-food life stages to food-producing minor species. This rule will, among other things, specify the procedures for requesting eligibility for indexing and for requesting addition to the index as well as the reporting requirements for index holders. This rule will also describe the criteria requestors will use for assembling a qualified expert panel to evaluate for FDA the target animal safety and effectiveness of a new animal drug proposed for indexing. 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda   Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 516 (To search for a specific CFR, visit the Code of Federal Regulations.
Legal Authority: 21 USC 360 ccc-1 
Legal Deadline:
Action Source Description Date
NPRM  Statutory    02/02/2009 
Final  Statutory    08/02/2010 
Timetable:
Action Date FR Cite
NPRM  08/22/2006  71 FR 48840 
NPRM Comment Period Extended  10/02/2006  71 FR 57892 
NPRM Comment Period End  12/20/2006   
Final Action  03/00/2008   
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: Businesses  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Bernadette Dunham
Director, Office of Minor Use and Minor Species Animal Drug Development
Department of Health and Human Services
Food and Drug Administration
HFV-101, Center for Veterinary Medicine (HFV-50, MPN-4), Room 180, 7519 Standish Place,
Rockville, MD 20855
Phone:240 276-9000
Fax:240 276-9001
Email: bernadette.dunham@fda.hhs.gov

 
Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us